This means that the body requires fewer calories to function, which can lead to a slowing of weight loss over time
October 2023: A Significant Shift in FAA Policy In September and October 2023, the FAA introduced major changes that streamlined medical certification protocol and expanded eligibility for certain weight loss medications, including GLP-1 receptor agonists such as: Semaglutide (Wegovy) Liraglutide (Saxenda) Tirzepatide (Zepbound, Mounjaro) Rather than issuing blanket prohibitions, the FAA established specific pathways for certification (including a fast-track), observation periods, documentation requirements and ongoing monitoring
Doctors are loving them, and seem to be prescribing them a lot
You may expect the final decision to require deep research the search results support a short checklist
The timeline for weight loss effects reflects this, with meaningful appetite changes emerging at 4 to 8 weeks of escalating doses
There is no specific diet to follow, but eating in a certain way may help reduce side effects and make the medications more effective